Atlas Trials

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB

Clinical trial NCT02375698 · COMPLETED

Trial details

NCT number
NCT02375698
Sponsor
Aeras
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2014-11-21
Primary completion
2016-06-24
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.